Literature DB >> 20226921

Influence of morbid obesity on parathyroidectomy outcomes in primary hyperparathyroidism.

Susan C Pitt1, Rajarajan Panneerselvan, Rebecca S Sippel, Herbert Chen.   

Abstract

BACKGROUND: We sought to evaluate the influence of morbid obesity in patients undergoing parathyroidectomy for primary hyperparathyroidism (pHPT).
METHODS: All patients with pHPT who underwent parathyroidectomy at a single institution between July 2002 and October 2008 were included. Body mass index (BMI), laboratory values, operative findings, and outcomes were examined.
RESULTS: Two hundred thirteen of the 776 patients identified (28%) were morbidly obese (BMI>or=35 kg/m2). When compared with nonmorbidly obese patients, the morbidly obese patients were younger, had higher preoperative intact parathyroid hormone (iPTH) levels, heavier parathyroids, and required overnight stay more often (P<.05 for all). However, the rates of complications, eucalcemia, and recurrence were similar for all patients.
CONCLUSION: In this study, more than a quarter of the patients who underwent parathyroidectomy for pHPT were morbidly obese and had significantly higher preoperative iPTH levels, heavier parathyroids, and longer hospital stay but similar rates of complications and operative success. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20226921      PMCID: PMC2841054          DOI: 10.1016/j.amjsurg.2009.08.024

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  16 in total

1.  Surgery for primary hyperparathyroidism: what is the best approach?

Authors:  Herbert Chen
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

2.  Increased body mass index and peri-operative risk in patients undergoing non-cardiac surgery.

Authors:  Joachim Klasen; Axel Junger; Bernd Hartmann; Andreas Jost; Matthias Benson; Tsovinar Virabjan; Gunter Hempelmann
Journal:  Obes Surg       Date:  2004-02       Impact factor: 4.129

3.  Association between primary hyperparathyroidism and increased body weight: a meta-analysis.

Authors:  Mark J Bolland; Andrew B Grey; Greg D Gamble; Ian R Reid
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

4.  Outcome of laparoscopic Nissen fundoplication in patients with body mass index >or=35.

Authors:  M Anvari; F Bamehriz
Journal:  Surg Endosc       Date:  2005-12-06       Impact factor: 4.584

5.  Impact of obesity on surgical outcomes after colorectal resection.

Authors:  S Benoist; Y Panis; A Alves; P Valleur
Journal:  Am J Surg       Date:  2000-04       Impact factor: 2.565

6.  A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable?

Authors:  Herbert Chen; Eberhard Mack; James R Starling
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

7.  The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery.

Authors:  Nahid Hamoui; Kiwan Kim; Gary Anthone; Peter F Crookes
Journal:  Arch Surg       Date:  2003-08

8.  Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy.

Authors:  Timothy K Williams; Ernest L Rosato; Eugene P Kennedy; Karen A Chojnacki; Jocelyn Andrel; Terry Hyslop; Cataldo Doria; Patricia K Sauter; Jordan Bloom; Charles J Yeo; Adam C Berger
Journal:  J Am Coll Surg       Date:  2008-12-18       Impact factor: 6.113

9.  Effect of body mass index on short-term outcomes after colectomy for cancer.

Authors:  Ryan P Merkow; Karl Y Bilimoria; Martin D McCarter; David J Bentrem
Journal:  J Am Coll Surg       Date:  2008-10-31       Impact factor: 6.113

10.  Calcium metabolism in the morbidly obese.

Authors:  Nahid Hamoui; Gary Anthone; Peter F Crookes
Journal:  Obes Surg       Date:  2004-01       Impact factor: 4.129

View more
  1 in total

1.  The impact of obesity on the presentation of primary hyperparathyroidism.

Authors:  Hien Tran; Jacob S Grange; Beverley Adams-Huet; Fiemu E Nwariaku; Jennifer L Rabaglia; Stacey L Woodruff; Shelby A Holt; Naim M Maalouf
Journal:  J Clin Endocrinol Metab       Date:  2014-03-31       Impact factor: 5.958

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.